Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice.
Nadine NagyGernot KaberMichael J KratochvilHedwich F KuipersShannon M RuppertKoshika YadavaJason YangSarah C HeilshornSarah Alice LongAlberto PugliesePaul L BollykyPublished in: Diabetologia (2020)
Hydrogel delivery may reduce the number of injections required in IL-2 treatment protocols for autoimmune diabetes. Graphical abstract.